Citigroup
NARI

Citigroup’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Citigroup’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-81,578
Closed -$4.16M – 6084
2024
Q4 		$4.16M Buy
81,578
+16,096
+25% +$791K ﹤0.01% 2155
2024
Q3 		$2.7M Buy
65,482
+27,919
+74% +$1.34M ﹤0.01% 2402
2024
Q2 		$1.81M Buy
37,563
+5,016
+15% +$222K ﹤0.01% 2432
2024
Q1 		$1.56M Sell
32,547
-8,112
-20% -$433K ﹤0.01% 2643
2023
Q4 		$2.64M Buy
40,659
+3,118
+8% +$188K ﹤0.01% 2013
2023
Q3 		$2.46M Buy
37,541
+18,002
+92% +$1.13M ﹤0.01% 1860
2023
Q2 		$1.14M Buy
19,539
+13,572
+227% +$856K ﹤0.01% 2753
2023
Q1 		$368K Sell
5,967
-1,382
-19% -$82.9K ﹤0.01% 3341
2022
Q4 		$467K Sell
7,349
-5,504
-43% -$399K ﹤0.01% 3225
2022
Q3 		$933K Buy
12,853
+5,645
+78% +$420K ﹤0.01% 2784
2022
Q2 		$491K Buy
7,208
+1,489
+26% +$107K ﹤0.01% 3240
2022
Q1 		$518K Sell
5,719
-7,277
-56% -$596K ﹤0.01% 3475
2021
Q4 		$1.19M Buy
12,996
+4,795
+58% +$411K ﹤0.01% 3078
2021
Q3 		$665K Sell
8,201
-119
-1% -$10K ﹤0.01% 3420
2021
Q2 		$777K Buy
8,320
+870
+12% +$84.3K ﹤0.01% 3417
2021
Q1 		$798K Buy
7,450
+15
+0.2% +$1.56K ﹤0.01% 3139
2020
Q4 		$649K Buy
7,435
+5,319
+251% +$376K ﹤0.01% 3976
2020
Q3 		$146K Buy
+2,116
New +$136K ﹤0.01% 4839

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Citigroup's NARI Position: Q1 2025 in Review

Citigroup sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 81,578 shares — an estimated $4.16M sold.

Citigroup first reported a position in NARI in Q3 2020 and held it in 18 quarters. The position peaked at $4.16M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Citigroup reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Citigroup sold 81,578 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $4.16M.
  • Citigroup first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 18 quarters.
  • Citigroup's Inari Medical, Inc. Common Stock position peaked at $4.16M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.